CAPITAL FUND MANAGEMENT S.A. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPITAL FUND MANAGEMENT S.A. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,320,761
-34.8%
86,370
-13.5%
0.01%
-42.9%
Q2 2023$3,559,616
+32.6%
99,821
-5.6%
0.01%
+7.7%
Q1 2023$2,685,161
-14.5%
105,715
+36.5%
0.01%
-38.1%
Q4 2022$3,140,479
-99.9%
77,428
+5.4%
0.02%
+10.5%
Q3 2022$2,426,927,000
+14.6%
73,432
+22.1%
0.02%0.0%
Q2 2022$2,117,001,000
+1.1%
60,125
+32.0%
0.02%
+11.8%
Q1 2022$2,094,568,000
+40.0%
45,544
+90.0%
0.02%
+54.5%
Q3 2021$1,496,447,000
+18.7%
23,970
-17.9%
0.01%
-45.0%
Q2 2020$1,260,629,000
+575529.7%
29,188
+284.1%
0.02%
+566.7%
Q1 2020$219,000
-97.9%
7,600
-95.3%
0.00%
-96.3%
Q4 2019$10,283,000
+91.7%
162,126
-14.8%
0.08%
+68.8%
Q3 2019$5,363,000
+1.5%
190,301
-4.6%
0.05%0.0%
Q2 2019$5,283,000
+173.0%
199,375
+89.1%
0.05%
+182.4%
Q1 2019$1,935,000105,4330.02%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders